Suppr超能文献

AStar自动抗菌检测系统对阳性血培养物中革兰氏阴性菌的评估

An Evaluation of the ASTar Automated Antimicrobial Testing System for Gram-Negative Bacteria in Positive Blood Cultures.

作者信息

Coulson Hannah, Ivin Angelo, Day Kathryn M, Fenwick Danielle J C, Marrs Emma C L, Mpwilu Patrick, Perry John D

机构信息

Microbiology Department, Freeman Hospital, Newcastle upon Tyne NE7 7DN, UK.

出版信息

Antibiotics (Basel). 2025 Mar 1;14(3):249. doi: 10.3390/antibiotics14030249.

Abstract

: Prompt administration of optimal antibiotic therapy is essential in the management of bacteraemia to reduce morbidity and mortality and to facilitate antibiotic stewardship. To identify the most effective therapy, rapid and accurate antimicrobial susceptibility testing (AST) is essential. ASTar is an automated AST system that delivers minimum inhibitory concentrations (MICs) for 23 antimicrobials and is designed for testing Gram-negative bacteria directly from positive blood cultures, with results available after 6 h. : The ASTar system was evaluated with 64 positive blood cultures from patients with bacteraemia and 56 simulated blood cultures inoculated with a range of antibiotic-resistant isolates. The ASTar results for 12 antibiotics commonly used in our hospitals were compared with the results derived from three different methods of disc susceptibility testing and MICs determined by broth microdilution (BMD). : For 121 isolates of Gram-negative bacteria, ASTar showed an average essential agreement of 87.2% and an average categorical agreement of 94%, when compared with BMD. Very major errors (false susceptibility) and major errors (false resistance) were associated with 0.9% and 3.4% of results, respectively. The results were at least as accurate as those obtained from EUCAST disc susceptibility methods (both rapid and overnight methods). : The ASTar system is an effective method for delivering accurate and rapid (6 h) AST results for Gram-negative bacteria by the direct testing of positive blood cultures.

摘要

及时给予最佳抗生素治疗对于菌血症的管理至关重要,可降低发病率和死亡率,并促进抗生素管理。为了确定最有效的治疗方法,快速准确的抗菌药物敏感性试验(AST)必不可少。ASTar是一种自动化AST系统,可提供23种抗菌药物的最低抑菌浓度(MIC),专为直接从阳性血培养物中检测革兰氏阴性菌而设计,6小时后可获得结果。:使用来自菌血症患者的64份阳性血培养物和接种了一系列耐药菌株的56份模拟血培养物对ASTar系统进行了评估。将我院常用的12种抗生素的ASTar结果与三种不同纸片药敏试验方法以及肉汤微量稀释法(BMD)测定的MIC结果进行了比较。:对于121株革兰氏阴性菌,与BMD相比,ASTar显示平均基本一致率为87.2%,平均分类一致率为94%。极重大错误(假敏感)和重大错误(假耐药)分别与0.9%和3.4%的结果相关。结果至少与从EUCAST纸片药敏试验方法(快速和过夜方法)获得的结果一样准确。:ASTar系统是一种通过直接检测阳性血培养物为革兰氏阴性菌提供准确快速(6小时)AST结果的有效方法。

相似文献

7
Evaluation of three protocols for direct susceptibility testing for Gram-negative rods from flagged positive blood culture bottles.
Microbiol Spectr. 2024 Apr 2;12(4):e0308123. doi: 10.1128/spectrum.03081-23. Epub 2024 Mar 6.
8
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections: a real world prospective study.
Eur J Clin Microbiol Infect Dis. 2025 Apr;44(4):847-853. doi: 10.1007/s10096-025-05046-3. Epub 2025 Jan 25.

本文引用的文献

1
Rapid Detection of Carbapenemases Using NG-Test CARBA 5 in Positive Blood Cultures: A Diagnostic Test Study.
Antibiotics (Basel). 2024 Nov 20;13(11):1105. doi: 10.3390/antibiotics13111105.
4
Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis.
Microorganisms. 2024 Sep 3;12(9):1824. doi: 10.3390/microorganisms12091824.
5
A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infections.
J Clin Microbiol. 2024 Oct 16;62(10):e0045824. doi: 10.1128/jcm.00458-24. Epub 2024 Sep 26.
8
The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream Infections.
Infect Dis Clin Microbiol. 2024 Jun 28;6(2):123-132. doi: 10.36519/idcm.2024.334. eCollection 2024 Jun.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验